Quavonlimab Antibody
Quavonlimab (MK-1308) is a human anti-CTLA-4 monoclonal antibody. Its combination with pembrolizumab demonstrates promising anti-tumor activity and a manageable safety profile in advanced NSCLC research, supporting its investigation in both in vitro and in vivo immuno-oncology studies.
Product Specifications
Product Name Alternative
MK1308, MK-1308
Target
Others
Clonality
Monoclonal
Conjugation
Unconjugated
Concentration
6.49 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
144.22 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
